Long-term disease stability assessed by the expanded disability status scale in patients treated with Cladribine tablets in the CLARITY and CLARITY extension studies
Giovannoni G, Comi G, Rammohan K, Rieckmann P, Vermersch P, Dangond F, Keller B, Jack D (2019)
Publication Type: Conference contribution
Publication year: 2019
Journal
Publisher: SAGE PUBLICATIONS LTD
City/Town: LONDON
Pages Range: 873-874
Conference Proceedings Title: MULTIPLE SCLEROSIS JOURNAL
Event location: Stockholm
DOI: 10.1016/j.jns.2019.10.291
Additional Organisation(s)
Involved external institutions
University of Miami
United States (USA) (US)
Medical Park AG
Germany (DE)
Merck KGaA
Germany (DE)
LILLE 1 University - Science and Technology
France (FR)
EMD Serono
United States (USA) (US)
Queen Mary University of London
United Kingdom (GB)
Università Vita-Salute San Raffaele (UniSR)
Italy (IT)
United States (USA) (US)
Medical Park AG
Germany (DE)
Merck KGaA
Germany (DE)
LILLE 1 University - Science and Technology
France (FR)
EMD Serono
United States (USA) (US)
Queen Mary University of London
United Kingdom (GB)
Università Vita-Salute San Raffaele (UniSR)
Italy (IT)
How to cite
APA:
Giovannoni, G., Comi, G., Rammohan, K., Rieckmann, P., Vermersch, P., Dangond, F.,... Jack, D. (2019). Long-term disease stability assessed by the expanded disability status scale in patients treated with Cladribine tablets in the CLARITY and CLARITY extension studies. In MULTIPLE SCLEROSIS JOURNAL (pp. 873-874). Stockholm, SE: LONDON: SAGE PUBLICATIONS LTD.
MLA:
Giovannoni, G., et al. "Long-term disease stability assessed by the expanded disability status scale in patients treated with Cladribine tablets in the CLARITY and CLARITY extension studies." Proceedings of the 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm LONDON: SAGE PUBLICATIONS LTD, 2019. 873-874.
BibTeX: Download